These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16389646

  • 1. Influence of C-peptide on early glomerular changes in diabetic mice.
    Maezawa Y, Yokote K, Sonezaki K, Fujimoto M, Kobayashi K, Kawamura H, Tokuyama T, Takemoto M, Ueda S, Kuwaki T, Mori S, Wahren J, Saito Y.
    Diabetes Metab Res Rev; 2006; 22(4):313-22. PubMed ID: 16389646
    [Abstract] [Full Text] [Related]

  • 2. Combined effects of moderately elevated blood glucose and locally produced TGF-beta1 on glomerular morphology and renal collagen production.
    Krag S, Nyengaard JR, Wogensen L.
    Nephrol Dial Transplant; 2007 Sep; 22(9):2485-96. PubMed ID: 17452404
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin II stimulates alpha3(IV) collagen production in mouse podocytes via TGF-beta and VEGF signalling: implications for diabetic glomerulopathy.
    Chen S, Lee JS, Iglesias-de la Cruz MC, Wang A, Izquierdo-Lahuerta A, Gandhi NK, Danesh FR, Wolf G, Ziyadeh FN.
    Nephrol Dial Transplant; 2005 Jul; 20(7):1320-8. PubMed ID: 15840669
    [Abstract] [Full Text] [Related]

  • 4. Galectin-9 inhibits glomerular hypertrophy in db/db diabetic mice via cell-cycle-dependent mechanisms.
    Baba M, Wada J, Eguchi J, Hashimoto I, Okada T, Yasuhara A, Shikata K, Kanwar YS, Makino H.
    J Am Soc Nephrol; 2005 Nov; 16(11):3222-34. PubMed ID: 16177004
    [Abstract] [Full Text] [Related]

  • 5. Tranilast prevents the progression of experimental diabetic nephropathy through suppression of enhanced extracellular matrix gene expression.
    Akahori H, Ota T, Torita M, Ando H, Kaneko S, Takamura T.
    J Pharmacol Exp Ther; 2005 Aug; 314(2):514-21. PubMed ID: 15857946
    [Abstract] [Full Text] [Related]

  • 6. Suppressions of chronic glomerular injuries and TGF-beta 1 production by HGF in attenuation of murine diabetic nephropathy.
    Mizuno S, Nakamura T.
    Am J Physiol Renal Physiol; 2004 Jan; 286(1):F134-43. PubMed ID: 14519594
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats.
    Yuan J, Jia R, Bao Y.
    J Renin Angiotensin Aldosterone Syst; 2007 Sep; 8(3):118-26. PubMed ID: 17907099
    [Abstract] [Full Text] [Related]

  • 8. [Effect of selective cyclooxygenase -2 inhibitor on the renal lesion of streptozotocin-induced diabetic rats and its possible mechanism].
    Zuo Y, Gu Y, Ma J, Lin S.
    Zhonghua Yi Xue Za Zhi; 2002 Feb 25; 82(4):239-43. PubMed ID: 11953170
    [Abstract] [Full Text] [Related]

  • 9. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2005 Mar 25; 20(3):532-8. PubMed ID: 15665028
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effects of C-peptide on renal morphology in diabetic rats.
    Sun W, Gao X, Zhao X, Cui D, Xia Q.
    Acta Biochim Biophys Sin (Shanghai); 2010 Dec 25; 42(12):893-9. PubMed ID: 21106770
    [Abstract] [Full Text] [Related]

  • 11. Deletion of protein kinase C-beta isoform in vivo reduces renal hypertrophy but not albuminuria in the streptozotocin-induced diabetic mouse model.
    Meier M, Park JK, Overheu D, Kirsch T, Lindschau C, Gueler F, Leitges M, Menne J, Haller H.
    Diabetes; 2007 Feb 25; 56(2):346-54. PubMed ID: 17259378
    [Abstract] [Full Text] [Related]

  • 12. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
    Daniel C, Schaub K, Amann K, Lawler J, Hugo C.
    Diabetes; 2007 Dec 25; 56(12):2982-9. PubMed ID: 17878288
    [Abstract] [Full Text] [Related]

  • 13. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats.
    Samnegård B, Jacobson SH, Johansson BL, Ekberg K, Isaksson B, Wahren J, Sjöquist M.
    Nephrol Dial Transplant; 2004 Jun 25; 19(6):1385-91. PubMed ID: 15004258
    [Abstract] [Full Text] [Related]

  • 14. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
    Liao J, Kobayashi M, Kanamuru Y, Nakamura S, Makita Y, Funabiki K, Horikoshi S, Tomino Y.
    J Nephrol; 2003 Jun 25; 16(6):841-9. PubMed ID: 14736011
    [Abstract] [Full Text] [Related]

  • 15. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM, del Re E, Brown D, Lin HY.
    Diabetes; 2007 Feb 25; 56(2):380-8. PubMed ID: 17259382
    [Abstract] [Full Text] [Related]

  • 16. An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy.
    Han SY, Jee YH, Han KH, Kang YS, Kim HK, Han JY, Kim YS, Cha DR.
    Nephrol Dial Transplant; 2006 Sep 25; 21(9):2406-16. PubMed ID: 16728425
    [Abstract] [Full Text] [Related]

  • 17. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
    Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, Kouahou M, Han DC, Kalluri R, Mundel P, Chen S.
    Kidney Int; 2002 Sep 25; 62(3):901-13. PubMed ID: 12164872
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli.
    Xu ZG, Miao LN, Cui YC, Jia Y, Yuan H, Wu M.
    Nephrol Dial Transplant; 2009 Jun 25; 24(6):1744-52. PubMed ID: 19103735
    [Abstract] [Full Text] [Related]

  • 19. Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.
    Cohen MP, Lautenslager GT, Shearman CW.
    Metabolism; 2001 Dec 25; 50(12):1435-40. PubMed ID: 11735089
    [Abstract] [Full Text] [Related]

  • 20. P-Cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies.
    Xu ZG, Ryu DR, Yoo TH, Jung DS, Kim JJ, Kim HJ, Choi HY, Kim JS, Adler SG, Natarajan R, Han DS, Kang SW.
    Nephrol Dial Transplant; 2005 Mar 25; 20(3):524-31. PubMed ID: 15647309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.